Program

The conference will include 3 tracks:

Plenary presentations from leaders in the field

Daily Working Group Updates and Discussion Sessions on Precision Medicine for:

  • Type 1 diabetes
  • Gestational diabetes
  • Type 2 Diabetes
  • Monogenic diabetes

Short Oral Presentations (E-posters) with mentored discussions, with focus on early career participants, mentorship and meet-the-professor sessions


Programs


PDM2021. PRELIMINARY PROGRAM

Each day of the virtual conference will include a series of plenary talks from key stakeholders and experts in various aspects of precision diabetes medicine, followed by a featured keynote talk from an individual living with diabetes. The Virtual Poster Hall will be open during the entirety of the virtual event to showcase scientific efforts in the field.

Day 1 (8:00-10:00 EST): Vision and Direction of the Precision Medicine for Diabetes Initiative
Welcome and opening remarks
Tracey Brown, CEO, American Diabetes Association
Opening remarks
Stefano Del Prato, President, European Association for the Study of Diabetes
Keynote: The Precision Medicine in Diabetes Initiative – Treating the Whole Person
Robert Gabbay, Chief Scientific and Medical Officer, American Diabetes Association
Keynote: Real Life Needs of People with Diabetes.
Dana Lewis, US, living with type 1 diabetes
Precision Medicine and the Research Agenda for Diabetes
William Cefalu, Director, Division of Diabetes, Endocrinology and Metabolic Disease, NIDDK
The Precision Medicine in Diabetes Initiative – Vision and Future Direction
Paul Franks, Co-Chair, Lund University Diabetes Center, Sweden
A Vision for Future Diabetes Care based on Precision.
Martin Ridderstråle, Senior Vice President and Head of Patient Care, Novo Nordisk Foundation
Day 2 (9:00-11:30 EST): Clinical and Scientific Challenges and Opportunities for Precision Diabetes Medicine
Keynote: Personalizing Diabetes Care in 2021
John Buse, Chief, Division of Endocrinology, University of North Carolina at Chapel Hill
Keynote: Living and staying healthy with type 2 diabetes
Adithya Menon, India, living with type 2 diabetes
Precision Diabetes in South Asians
V Mohan, Chair, Dr Mohan’s Diabetes Specialties Centre, Chennai, India
Sub-classification of diabetes: Possibilities and Challenges.
Miriam Udler, Massachusetts General Hospital and Broad Institute, Boston, US
Precision Approach to Diabetes in Pregnancy
Marie-France Hivert, Dept of Population Medicine, Harvard Medical School
Approach to Precision Medicine for ‘Common’ Type 2 diabetes

Chris Rhodes, Chief Scientist, Cardiovascular, Renal and Metabolism, Astra Zeneca, Gaithersburg, MD, US

Precision Prevention of Type 1 Diabetes
Jessica Dunne, Janssen Pharmaceuticals, New Jersey, US
11:10-11:30 Panel discussion
Day 3 (9:00-11:20 EST): From History to Future Policy— Broader Context for Precision Diabetes Medicine
Keynote: Precision Diabetes Care – a historical perspective on race and disease
Arleen Tuchman, Nelson O. Tyrone Jr. Professor of History, Vanderbilt University
Keynote: The Importance of the Diagnosis
Kristin Skiados, living with monogenic diabetes
Precision Monitoring and Technology in Diabetes Care
David Klonoff, Director, Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, California
Precision Monitoring – Approach to Policy Implementation
Dirk Mueller-Wieland, Head Clinical Research Centre, Dept of Medicine, University of Aachen, Germany
Public-private partnerships in the research approach to Precision Medicine
Bernd Stowasser, Sanofi, IMI Strategic Governance Group, Diabetes & Metabolic Disorders
The Accelerating Medicines Partnership in Type 2 Diabetes.
Philip Smith, Division of Diabetes, Endocrinology & Metabolic Diseases, NIDDK
Thoughts on Precision Medicine in Diabetes: an Industry Perspective.
Speaker: Rasmus Rabøl, Corporate Vice President, Clinical Pharmacology and Translational Medicine, Novo Nordisk
11:10-11:20 Panel discussion, transition to Closing Remarks (11:20-11:30)